What Is Oxaloacetate and What Does It Do?

Oxaloacetate is a four-carbon organic acid that sits at one of the busiest intersections in your metabolism. It is the molecule that keeps the citric acid cycle turning, the starting material for making new glucose when your blood sugar drops, and a shuttle component that moves energy between different compartments of your cells. Despite being present in only tiny concentrations at any given moment, it is so central to energy production that a shortage of it can cripple entire metabolic pathways. Researchers have also been exploring oxaloacetate as a supplement, with early studies suggesting it may mimic some effects of calorie restriction, reduce certain types of fatigue, and even scavenge a brain chemical linked to neurological damage.

The Hub of Cellular Energy Production

The citric acid cycle, sometimes called the Krebs cycle, is the set of chemical reactions your cells use to extract energy from food. Oxaloacetate both starts and finishes this cycle. At the beginning of each turn, oxaloacetate combines with a two-carbon fragment called acetyl-CoA to form citrate. Over the course of several reactions, citrate is broken down, energy is harvested, and the cycle regenerates oxaloacetate so the process can start again. Without oxaloacetate to accept that acetyl-CoA, the cycle stalls and your cells lose their primary way of producing usable energy.

The enzyme pyruvate carboxylase is responsible for topping off the supply. It converts pyruvate into oxaloacetate, a reaction that replenishes the citric acid cycle when intermediates get siphoned off for other tasks like building amino acids or making glucose.¹ This refilling process is called anaplerosis, and it keeps the cycle spinning even when your body is pulling metabolites in multiple directions at once.

Oxaloacetate is also the gateway to gluconeogenesis, the process your liver uses to manufacture glucose from non-sugar sources when you haven’t eaten for a while. Gluconeogenesis begins in the mitochondria with the synthesis of oxaloacetate from pyruvate and other citric acid cycle intermediates.² From there, oxaloacetate is converted to phosphoenolpyruvate, which eventually becomes glucose. This is why oxaloacetate levels matter during fasting, intense exercise, or any state where the body needs to produce its own sugar supply.

Moving Energy Across Membranes

Your cells face a logistical problem: energy-carrying molecules produced in one compartment often need to reach another compartment, but the inner membrane of the mitochondria won’t let certain molecules through. The solution involves oxaloacetate as part of a relay system called the malate-aspartate shuttle.

The inner mitochondrial membrane is impermeable to NADH, the electron carrier that delivers energy to the machinery that makes ATP. To get those electrons across, the shuttle converts oxaloacetate to malate in the cytoplasm, which can cross the membrane. Once inside the mitochondria, malate is converted back, releasing NADH where it can feed into energy production.³ The reverse leg of the shuttle uses an enzyme called aspartate aminotransferase, which interconverts oxaloacetate and aspartate while simultaneously converting glutamate to alpha-ketoglutarate.⁴ This same enzyme, sometimes called glutamate-oxaloacetate transaminase, plays a role in amino acid metabolism throughout the body and becomes relevant later when we get to brain health.⁵

The practical upshot is that oxaloacetate doesn’t just participate in one pathway. It is the shared currency between energy production, glucose manufacturing, amino acid handling, and the transfer of reducing power across membranes. Disrupting any one of these roles has cascading effects on the others.

A Molecule That Falls Apart Quickly

One of the oddities of oxaloacetate is how unstable it is. In a water-based solution at room temperature, it spontaneously breaks down into pyruvate and carbon dioxide, with a half-life of roughly 14 hours.⁶ The primary culprit is the monoanion form of the molecule, which decarboxylates on its own without needing any enzyme to push it along.⁷

This instability explains why oxaloacetate concentrations inside your cells are vanishingly small compared to most other citric acid cycle intermediates. The molecule is made, used, and remade constantly rather than stockpiled. It also creates challenges for anyone trying to deliver oxaloacetate as an oral supplement: the molecule starts degrading as soon as it’s in solution, and formulation has to account for that. Supplement manufacturers have worked around this by using thermally stabilized salts, but the fundamental chemistry remains a constraint.

Mimicking Calorie Restriction

Some of the most intriguing research on oxaloacetate has nothing to do with its standard metabolic job. In animal studies, supplemental oxaloacetate activates some of the same molecular pathways that calorie restriction does, raising the question of whether you could get certain health benefits of eating less without actually eating less.

In the roundworm C. elegans, supplementation with oxaloacetate increased median lifespan by about 25% and maximum lifespan by about 13%. The effect depended on AMPK, an energy-sensing enzyme, and the transcription factor FOXO/DAF-16, both of which are known players in the longevity benefits of calorie restriction.⁸ The proposed mechanism involves a shift in the ratio of NAD+ to NADH, the same shift that calorie restriction produces. Essentially, oxaloacetate appears to trick the cell’s energy-sensing machinery into behaving as if fewer calories are available.

Broader reviews of the animal data describe additional benefits including protection of mitochondrial DNA and protective effects on retinal, neural, and pancreatic tissue.⁹ These are encouraging signals, but it’s worth being clear-eyed about the gap between worm studies and human medicine. Calorie-restriction mimetics have a long history of looking promising in simple organisms and then failing to deliver the same dramatic results in mammals. The lifespan data in humans simply doesn’t exist yet.

Brain Health and Glutamate Scavenging

Glutamate is the brain’s most abundant excitatory neurotransmitter, but too much of it outside cells is toxic. After a stroke, traumatic brain injury, or brain hemorrhage, glutamate floods into the bloodstream and surrounding tissue, killing neurons. One approach to reducing this damage is to lower blood glutamate levels so that the concentration gradient draws excess glutamate out of the brain and into the blood, where it can be cleared.

Oxaloacetate acts as a glutamate scavenger because the enzyme glutamate-oxaloacetate transaminase converts glutamate and oxaloacetate into aspartate and alpha-ketoglutarate. In rat models, administering oxaloacetate reduced blood glutamate concentrations and improved neurological outcomes after subarachnoid hemorrhage.¹⁰ The logic is elegant: rather than trying to block glutamate receptors in the brain, you exploit the body’s own enzymatic machinery to drain the excess.

Researchers have begun testing this concept in Alzheimer’s disease, where chronic glutamate excitotoxicity and impaired brain energy metabolism are both implicated. A small clinical trial in Alzheimer’s patients found that a higher dose of oxaloacetate produced significant improvements in brain glucose metabolism across multiple regions, as measured by FDG-PET imaging. The higher dose also increased levels of glutathione, an important antioxidant, in several brain regions. However, no statistically significant changes in cognitive test scores were observed during the study period.¹¹ The study was designed primarily to assess safety and whether the supplement was hitting its biological targets, not to prove clinical efficacy, so the absence of cognitive improvement doesn’t close the door. But it does mean the clinical case is still very early.

Fatigue in ME/CFS and Long COVID

Perhaps the most developed area of oxaloacetate’s therapeutic research involves chronic fatigue. Myalgic encephalomyelitis/chronic fatigue syndrome is notoriously difficult to treat, and when Long COVID emerged with strikingly similar fatigue symptoms, researchers tested oxaloacetate in both groups.

An initial non-randomized trial of 76 ME/CFS patients found that fatigue scores dropped by roughly 22% to 28% over six weeks, depending on how the questionnaire was scored, with the improvement increasing at higher doses. Patients taking the highest dose saw about a 33% reduction in fatigue. Long COVID patients in the same study showed fatigue reductions of up to about 47%.¹² Both physical and mental fatigue improved.

A follow-up randomized controlled trial confirmed these results against a placebo. The oxaloacetate group saw fatigue drop by more than 25% from baseline, while the control group showed a non-significant improvement of roughly 10%. About 40% of the oxaloacetate group were classified as “enhanced responders,” averaging a 63% fatigue reduction.¹³ For a condition where virtually nothing has passed rigorous placebo-controlled testing, these numbers are noteworthy, though the trial was still relatively small and further replication is needed.

The proposed mechanism ties back to oxaloacetate’s basic metabolic role: by replenishing citric acid cycle intermediates and supporting mitochondrial energy production, it may address the cellular energy deficit that underlies the crushing fatigue these patients experience.

Cancer Metabolism

Cancer cells are famously hungry for glucose, relying heavily on glycolysis even when oxygen is plentiful. This metabolic rewiring, known as the Warburg effect, is one of the hallmarks of cancer biology. Oxaloacetate is relevant here because it sits at the junction between glycolysis and gluconeogenesis, and pushing cells toward gluconeogenesis could, in theory, starve them of the glycolytic fuel they depend on.

In laboratory and mouse studies of liver cancer, oxaloacetate promoted a metabolic shift away from glycolysis and toward gluconeogenesis through pathways involving the transcription factor FoxO1. It also triggered apoptosis in cancer cells. In a mouse model, oxaloacetate treatment significantly shrank tumors, and even tumors engineered to overexpress a growth-promoting protein still responded to treatment with reduced growth.¹⁴ These are preclinical findings in one cancer type, and they are very far from clinical use, but they illustrate how oxaloacetate’s ordinary metabolic function could become therapeutically relevant when cancer distorts normal metabolism.

The Exercise Paradox

Given all this talk of oxaloacetate supporting energy production, a 2024 study introduced a surprising wrinkle: in mouse skeletal muscle, elevated oxaloacetate actually contributed to fatigue. Researchers found that serum oxaloacetate levels correlated with fatigue in exercising mice, and administering oxaloacetate impaired exercise performance. The mechanism involved activation of JNK signaling and a mitochondrial uncoupling protein called UCP2, which essentially caused the muscle mitochondria to burn fuel without efficiently producing ATP. Knocking out UCP2 or blocking JNK completely reversed the effect.¹⁵

This seems contradictory: how can a molecule that supports cellular energy in one context drain it in another? The answer lies in tissue-specific responses and dosing context. Skeletal muscle has different metabolic demands and regulatory circuits than, say, the liver or brain. What helps replenish citric acid cycle intermediates in one tissue may trigger uncoupling and energy waste in another. This finding is a good reminder that metabolic molecules rarely do just one thing, and the effect depends heavily on where and how much of the molecule shows up.

What Happens When the Body Cannot Make Enough

The importance of oxaloacetate becomes especially clear when the body loses its ability to produce it. Pyruvate carboxylase deficiency is a rare genetic disorder in which the enzyme that converts pyruvate to oxaloacetate is absent or dysfunctional. Without that enzyme, oxaloacetate levels plummet, and the consequences are severe: the citric acid cycle can’t be adequately refueled, gluconeogenesis is impaired, and lactic acid builds up because pyruvate has nowhere productive to go.¹⁶ Affected infants typically present with lactic acidemia and neurological dysfunction early in life.

Liver biopsies from patients with this deficiency show dramatically low concentrations of oxaloacetate, citrate, alpha-ketoglutarate, and malate, all of which depend on oxaloacetate being available. In one case, calculated tissue oxaloacetate concentrations were so low that the citric acid cycle was effectively starved, unable to operate at normal rates.¹⁷ The clinical picture underscores that oxaloacetate is not a minor player in metabolism. It is a bottleneck, and when its supply fails, multiple systems collapse simultaneously.

Getting It Into the Body as a Supplement

Given the research interest, a practical question arises: can you just take oxaloacetate by mouth and expect it to reach your cells? The pharmacokinetics are tricky. A study in Alzheimer’s patients given 100 mg capsules found that plasma concentrations after dosing were only slightly higher than the levels already circulating naturally. Pre-dose concentrations of oxaloacetate were about 60% of the peak concentration after the first dose, and by day 28 the peak and pre-dose levels were virtually identical. No accumulation occurred over the month-long dosing period.¹⁸

This makes pharmacological sense given the molecule’s instability and its rapid conversion to pyruvate in solution. The body already makes and consumes oxaloacetate constantly, so adding a small oral dose barely moves the needle on plasma levels. The fatigue trials used substantially higher doses, ranging from 500 mg twice daily up to 1,000 mg three times daily, which may explain why those studies detected clinical effects. Older safety data from diabetic patients treated with up to 1 gram per day reported no adverse effects.⁸ Still, the gap between the 100 mg dose that barely registered pharmacokinetically and the higher doses showing clinical benefit suggests that dose selection is critical and that much of the oral dose may simply degrade before it gets where it needs to go.

A Role in the Origin of Life

Oxaloacetate’s centrality in biology may go all the way back to the beginning. One of the big puzzles in origin-of-life research is how the metabolic cycles we see today could have gotten started before enzymes existed. If the citric acid cycle requires enzymes, and enzymes require the citric acid cycle’s products, which came first?

Recent experiments suggest that parts of the cycle can run without enzymes at all. A study using zinc sulfide as a photocatalyst demonstrated that three of the five reductive steps in a reversed Krebs cycle can be driven by light, including the conversion of oxaloacetate to malate at high yield.¹⁹ Separately, researchers showed that nickel catalysts, including material from an actual meteorite, could convert oxaloacetate and other biological keto-acids into their corresponding amino acids using just hydrogen gas and ammonia.²⁰ Oxaloacetate gave rise to aspartate in these reactions, one of the twenty amino acids that make up proteins today.

These experiments don’t prove that oxaloacetate played this exact role on the early Earth, but they show that it can participate in biologically relevant chemistry without any biological machinery. For a molecule that seems purely utilitarian inside living cells, the idea that it may have helped build the chemical foundations of life itself gives it a grander place in the story of biology.

Oxaloacetate in Plant Photosynthesis

Oxaloacetate’s reach extends well beyond animal metabolism. In plants that use C4 photosynthesis, a category that includes corn, sugarcane, and many tropical grasses, oxaloacetate is the immediate product of the first carbon-fixing step. The enzyme PEP carboxylase grabs CO2 in the outer mesophyll cells of the leaf and attaches it to a three-carbon molecule, producing oxaloacetate. This four-carbon acid is then rapidly converted to malate or aspartate, which are shuttled to inner bundle-sheath cells where the CO2 is released and fed into the standard photosynthetic cycle.²¹

The whole purpose of this elaborate relay is to concentrate CO2 around the enzyme Rubisco, which is notoriously prone to grabbing oxygen instead of CO2 on hot, dry days. C4 plants evolved this workaround to photosynthesize more efficiently under conditions where C3 plants struggle, and oxaloacetate is the first molecule in that concentrating mechanism. It is short-lived in this role, converted almost as fast as it is made, which mirrors its behavior inside animal cells: always present, always turning over, never accumulating.